Literature DB >> 7588945

Gallium uptake in cerebrotendinous xanthomatosis.

J Okada1, H Oonishi, H Tamada, T Kizaki, K Yasumi, T Matuo.   

Abstract

In a patient with cerebrotendinous xanthomatosis, a rare familial sterol storage disease, increased uptake of gallium-67 was observed in the tendon xanthomas. This is considered to have resulted from the tumour-like proliferation of histiocytic cells in the xanthomas. Abnormalities in the white matter of the cerebellum and the brain stem observed by X-ray computed tomography and magnetic resonance imaging were not detected by 67Ga scintigraphy, possibly due to the small size of the CNS lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588945     DOI: 10.1007/BF00808420

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  13 in total

1.  Gallium-67 uptake in the lung of asbestos exposed sheep: early association with enhanced macrophage-derived fibronectin accumulation.

Authors:  R Bégin; G Bisson; R Lambert; Y Côté; D Fabi; M Martel; G Lamoureux; M Rola-Pleszczynski; M Boctor; D Dalle
Journal:  J Nucl Med       Date:  1986-04       Impact factor: 10.057

2.  Gallium 67 citrate scanning in patients with pulmonary sarcoidosis.

Authors:  A Heshiki; S L Schatz; K A McKusick; D W Bowersox; J S Soin; H N Wagner
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-12

3.  Cholestanolosis (cerebrotendinous xanthomatosis). A follow-up study on the original family.

Authors:  M Philippart; L Van Bogaert
Journal:  Arch Neurol       Date:  1969-12

4.  Cerebrotendinous xanthomatosis. Clinical and pathological studies.

Authors:  J R Schimschock; E C Alvord; P D Swanson
Journal:  Arch Neurol       Date:  1968-06

5.  Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system.

Authors:  J H Menkes; J R Schimschock; P D Swanson
Journal:  Arch Neurol       Date:  1968-07

6.  Scintigraphic visualization of extraosseous xanthomatosis.

Authors:  C Shigeno; R Morita; M Fukunaga; T Kitsugi; Y Kodama; M Hino; K Torizuka
Journal:  Eur J Nucl Med       Date:  1982

7.  Gallium-67 imaging in pulmonary eosinophilic granuloma.

Authors:  M C Makhija; G Davis
Journal:  Clin Nucl Med       Date:  1984-03       Impact factor: 7.794

8.  Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients.

Authors:  Y Hokezu; M Kuriyama; R Kubota; M Nakagawa; J Fujiyama; M Osame
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

9.  A transferrin-mediated uptake of gallium-67 by EMT-6 sarcoma. II. Studies in vivo (BALB/c mice): concise communication.

Authors:  S M Larson; J S Rasey; D R Allen; Z Grunbaum
Journal:  J Nucl Med       Date:  1979-08       Impact factor: 10.057

10.  Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis.

Authors:  Y Mimura; M Kuriyama; Y Tokimura; J Fujiyama; M Osame; K Takesako; N Tanaka
Journal:  J Neurol Sci       Date:  1993-02       Impact factor: 3.181

View more
  2 in total

1.  Spinal form cerebrotendinous xanthomatosis patient with long spinal cord lesion.

Authors:  Ryuta Abe; Yoshiki Sekijima; Tomomi Kinoshita; Tsuneaki Yoshinaga; Shingo Koyama; Takeo Kato; Shu-Ichi Ikeda
Journal:  J Spinal Cord Med       Date:  2016-02-25       Impact factor: 1.985

2.  Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.

Authors:  Shingo Koyama; Yoshiki Sekijima; Masatsune Ogura; Mika Hori; Kota Matsuki; Takashi Miida; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-08       Impact factor: 4.928

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.